Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Farmers Insurance
Chinese Patent Office
Deloitte
Boehringer Ingelheim

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 8,206,735

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,206,735
Title:Pharmaceutical compositions for sustained release delivery of peptides
Abstract: The present invention provides methods of forming a solid, biodegradable implant in-situ in a body by administering a liquid pharmaceutical composition comprising an effective amount of a biocompatible, water-insoluble, biodegradable polymer and an effective amount of a therapeutic peptide covalently modified with one or more lipophilic or amphiphilic moieties, which are dissolved or dispersed in a biocompatible, water-soluble organic solvent. This invention also provides related compositions and methods.
Inventor(s): Li; Yuhua (Newark, DE), Chien; Benjamin (Newark, DE)
Assignee: Foresee Pharmaceuticals, LLC (Newark, DE)
Application Number:11/827,260
Patent Claims:see list of patent claims

Details for Patent 8,206,735

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Try a Free Trial Foresee Pharmaceuticals, LLC (Newark, DE) 2026-07-11 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Try a Free Trial Foresee Pharmaceuticals, LLC (Newark, DE) 2026-07-11 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Try a Free Trial Foresee Pharmaceuticals, LLC (Newark, DE) 2026-07-11 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Try a Free Trial Foresee Pharmaceuticals, LLC (Newark, DE) 2026-07-11 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,206,735

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2008008363 Jan 17, 2008
United States of America 2008020016 Jan 24, 2008
United States of America 2012237476 Sep 20, 2012
United States of America 8840915 Sep 23, 2014
Russian Federation 2009103210 Aug 20, 2010
Russian Federation 2456018 Jul 20, 2012
Mexico 2009000434 Jan 29, 2009
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Federal Trade Commission
US Department of Justice
Harvard Business School
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.